Stockscreener 앱 받기
6.75
4.01%
0.26
Alpha Cognition Inc 주식(ACOG)의 최신 뉴스
Alpha Cognition Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Caledonian Record
Alpha Cognition Inc. (ACOG) soars 8.6%: Is further upside left in the stock? - MSN
Alpha Cognition Inc enters settlement agreement with Galantos Pharma on April 10, 2026SEC filing - marketscreener.com
Alpha Cognition IncEnters Settlement Agreement With Galantos Pharma On April 10, 2026SEC Filing - TradingView — Track All Markets
[8-K] Alpha Cognition Inc. Reports Material Event - Stock Titan
Alpha Cognition Earnings Call: Early Traction, Rising Costs - TipRanks
Is Alpha Cognition Inc a strong candidate for buy and hold2026 Macro Moves & Safe Entry Trade Reports - baoquankhu1.vn
Aug Reactions: Whats the MACD signal for Alpha Cognition Inc2026 Closing Moves & Weekly High Conviction Trade Ideas - baoquankhu1.vn
Aug Swings: Will Alpha Cognition Inc announce a stock splitMarket Volume Summary & Stock Timing and Entry Methods - baoquankhu1.vn
Sell Signal: What are the analyst revisions for BBAIWSIs Alpha Cognition Inc stock a good investment in YEARGap Up & Daily Entry Point Trade Alerts - baoquankhu1.vn
Portfolio Recap: What are the analyst revisions for BBAIWSIs Alpha Cognition Inc stock a good investment in YEAR2026 Key Highlights & Verified Short-Term Trading Plans - baoquankhu1.vn
Alpha Cognition Inc (OTC:ACOGF) Stock Quote - The Chronicle-Journal
Movement Recap: Can Alpha Cognition Inc stock double in the next yearMarket Trend Summary & AI Powered Market Entry Ideas - baoquankhu1.vn
Alpha Cognition (NASDAQ:ACOG) Lowered to "Sell" Rating by Wall Street Zen - MarketBeat
Alpha Cognition Inc. (ACOG) Jumps 8.6%: Does the Stock Have More Room to Grow? - Bitget
Alpha Cognition Inc. (ACOG) Soars 8.6%: Is Further Upside Left in the Stock? - Yahoo Finance
Alpha Cognition Receives Issued U.S. Patent for ALPHA-1062 for Treatment of Traumatic Brain Injury - BioSpace
Opaleye Management Inc. Increases Stake in Alpha Cognition Inc. - GuruFocus
Alpha Cognition receives U.S. patent for traumatic brain injury drug By Investing.com - Investing.com Australia
Alpha Cognition receives issued U.S. patent for Alpha-1062 for treatment of traumatic brain injury - marketscreener.com
Alpha Cognition Receives Issued U.S. Patent For Alpha-1062 For Treatment Of Traumatic Brain Injury - TradingView — Track All Markets
Alpha Cognition receives U.S. patent for traumatic brain injury drug - Investing.com
Alpha Cognition Gets US Patent for ALPHA-1062 in Traumatic Brain Injury - marketscreener.com
Alpha Cognition Reports Strong ZUNVEYL Adoption in Long-Term Care Facilities - citybuzz -
Stonegate Capital Partners Updates Coverage on Alpha Cognition Inc. (ACOG) Q425 - Nasdaq
Alpha Cognition (ACOG) Q4 2025 Earnings Transcript - The Globe and Mail
EV Market: Will Alpha Cognition Inc benefit from geopolitical trendsQuarterly Portfolio Report & Weekly High Potential Stock Alerts - baoquankhu1.vn
Alpha Cognition (NASDAQ: ACOG) outlines ZUNVEYL launch, $44M license and Alzheimer’s pipeline - Stock Titan
Opaleye fund adds Alpha Cognition (ACOG) stake with new share purchases - Stock Titan
Aug PreEarnings: Does Alpha Cognition Inc have declining or rising EPS2026 Geopolitical Influence & Technical Pattern Recognition Alerts - baoquankhu1.vn
Can Alpha Cognition Inc outperform under higher oil prices2026 AllTime Highs & Risk Controlled Stock Pick Alerts - baoquankhu1.vn
Alpha Cognition Reports Q4 Earnings, Highlights Continued ZUNVEYL Growth - National Today
Alpha Cognition (NASDAQ:ACOG) Posts Earnings Results, Misses Estimates By $0.03 EPS - marketbeat.com
Alpha Cognition Inc. Announces 2026 Annual General Meeting Date and Details for Security Holders - Minichart
Alpha Cognition Q4 Earnings Call Highlights - Defense World
Alpha Cognition schedules annual shareholder meeting for June 16 - uk.investing.com
Alpha Cognition schedules annual shareholder meeting for June 16 By Investing.com - Investing.com India
Alpha Cognition (NASDAQ: ACOG) sets June 16, 2026 annual shareholder meeting - Stock Titan
Alpha Cognition Inc. Common Stock Q4 2025 Earnings Call Summary - Yahoo Finance
Alpha Cognition reports Q4 revenue of $2.5M for Alzheimer’s drug - Investing.com Australia
Major Investor Quietly Boosts Stake in Alpha Cognition Inc. - TipRanks
Alpha Cognition Q4 2025 Earnings Call Transcript - MarketBeat
Alpha Cognition Inc. (ACOG) reports Q4 loss, lags revenue estimates - MSN
2.69%
0.25%
자본화:
|
볼륨(24시간):